AbCellera Biologics Investor Relations Material
Latest events
Q2 2025
AbCellera Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AbCellera Biologics Inc
Access all reports
AbCellera Biologics, Inc. operates as a biotechnology company. The Company offers antibody discovery platform that accelerates the design of therapeutic antibodies and helps researchers discover new treatments for people with cancer or Alzheimer's disease. The company's platform discovers and characterizes fully human antibodies from natural immune responses in order to provide insights into how best to stimulate the human immune system.
Key slides for AbCellera Biologics Inc
Q2 2025
AbCellera Biologics Inc
Q2 2025
AbCellera Biologics Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ABCL
Country
🇺🇸 United States